These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25466315)

  • 1. Insulin infusion therapy in critical care patients: regular insulin vs short-acting insulin. A prospective, crossover, randomized, multicenter blind study.
    Bilotta F; Badenes R; Lolli S; Belda FJ; Einav S; Rosa G
    J Crit Care; 2015 Apr; 30(2):437.e1-6. PubMed ID: 25466315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: the updated Yale insulin infusion protocol.
    Shetty S; Inzucchi SE; Goldberg PA; Cooper D; Siegel MD; Honiden S
    Endocr Pract; 2012; 18(3):363-70. PubMed ID: 22138078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
    Clergeau A; Parienti JJ; Reznik Y; Clergeau D; Seguin A; Valette X; du Cheyron D; Joubert M
    Diabetes Technol Ther; 2017 Feb; 19(2):115-123. PubMed ID: 28118045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes.
    Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB
    Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.
    Oghazian MB; Javadi MR; Radfar M; Torkamandi H; Sadeghi M; Hayatshahi A; Gholami K
    Pharmacotherapy; 2015 Feb; 35(2):148-57. PubMed ID: 25689245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
    Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
    Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
    Chant C; Wilson G; Friedrich JO
    Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Subcutaneous Regular Insulin and Lispro Insulin in Diabetics Receiving Continuous Nutrition: A Numerical Study.
    Stull MC; Strilka RJ; Clemens MS; Armen SB
    J Diabetes Sci Technol; 2015 Jun; 10(1):137-44. PubMed ID: 26134836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin therapy in practice: can we do it?
    Dossett LA; Collier B; Donahue R; Mowery NT; Dortch MJ; Guillamondegui O; Diaz JJ; May AK
    JPEN J Parenter Enteral Nutr; 2009; 33(1):14-20. PubMed ID: 18832598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial.
    Alsweiler JM; Harding JE; Bloomfield FH
    Pediatrics; 2012 Apr; 129(4):639-47. PubMed ID: 22430450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.
    Graffagnino C; Gurram AR; Kolls B; Olson DM
    Neurocrit Care; 2010 Dec; 13(3):307-12. PubMed ID: 21086066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does blood glucose control with metformin influence intensive insulin protocols? Evidence for involvement of oxidative stress and inflammatory cytokines.
    Ansari G; Mojtahedzadeh M; Kajbaf F; Najafi A; Khajavi MR; Khalili H; Rouini MR; Ahmadi H; Abdollahi M
    Adv Ther; 2008 Jul; 25(7):681-702. PubMed ID: 18636232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.
    de la Peña A; Seger M; Soon D; Scott AJ; Reddy SR; Dobbins MA; Brown-Augsburger P; Linnebjerg H
    Clin Pharmacol Drug Dev; 2016 Jan; 5(1):69-75. PubMed ID: 27119580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care.
    Cordingley JJ; Vlasselaers D; Dormand NC; Wouters PJ; Squire SD; Chassin LJ; Wilinska ME; Morgan CJ; Hovorka R; Van den Berghe G
    Intensive Care Med; 2009 Jan; 35(1):123-8. PubMed ID: 18661120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.
    Braithwaite SS; Edkins R; Macgregor KL; Sredzienski ES; Houston M; Zarzaur B; Rich PB; Benedetto B; Rutherford EJ
    Diabetes Technol Ther; 2006 Aug; 8(4):476-88. PubMed ID: 16939372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.